公开(公告)号：SG174211A1

公开(公告)日：2011-10-28

申请号：SG2011063179

申请日：2010-03-24

Applicant: ABBOTT LAB

Inventor： NAPIER JAMES J ,  CALIFANO JEAN-CHRISTOPHE ,  BECKER CALVIN L ,  YU SU

Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.

公开(公告)号：AU2010229975A1

公开(公告)日：2011-09-29

申请号：AU2010229975

申请日：2010-03-24

Applicant: ABBOTT LAB

Inventor： NAPIER JAMES J ,  CALIFANO JEAN-CHRISTOPHE ,  YU SU ,  BECKER CALVIN L

IPC: C07D239/54 ,  C07D311/08

Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that,, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.

公开(公告)号：CA2753825A1

公开(公告)日：2010-09-30

申请号：CA2753825

申请日：2010-03-24

Applicant: ABBOTT LAB

Inventor： NAPIER JAMES J ,  CALIFANO JEAN-CHRISTOPHE ,  YU SU ,  BECKER CALVIN L

IPC: C07D239/54 ,  C07D311/08

Abstract: This invention is directed to: (a) processes for preparing a compound and salts thereof that, inter alia, are useful for inhibiting hepatitis C virus (HCV); (b) intermediates useful for the preparation of the compound and salts; (c) pharmaceutical compositions comprising the compound or salts; and (d) methods of use of such compositions.